Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks.
At a ceremony at the company’s flagship clinical laboratory in Teterboro, NJ, the company’s chairman, president and CEO Steve Rusckowski presented Health In Your Hands grants of $50,000 to representatives from each organization. Paul Brown, M.D., founder and former CEO of Quest’s predecessor company Metropolitan Pathology Laboratory, Inc. or MetPath, established in April, 1967, was also recognized at the event.
To view the multimedia release go to:
https://www.multivu.com/players/English/8080751-quest-diagnostics-50th-anniversary/
Country Vacations provides a state-of-the-art Health Club, multi-cuisine restaurants, business centre, swimming pool and other facilities. http://www.countryvacationssrilanka.com/
West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC, today announced the completion of the first two phases of their four-phase strategic collaboration. The companies are working to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence and patient-engagement platform with West’s injectable drug delivery systems to provide an end-to-end connected health solution for pharmaceutical companies and the patients they serve. The combined offering will provide voluntary, electronically connected drug delivery systems that track when patients take their medication. The HealthPrize system engages and educates patients to increase adherence and medical literacy, rewarding interaction and compliance with prescribed treatment plans, and contributing to better health outcomes.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7625851-west-pharma-healthprize-tech-collaboration/
Building on a successful campaign that helped hundreds of thousands of Americans learn their risk of developing type 2 diabetes through campaign messaging and an online risk test, the first-of-its-kind initiative to raise national awareness of prediabetes returns with an entertaining new approach. The new campaign, launching today, encourages viewers to take a one-minute prediabetes risk test to know where they stand and discover how they can decrease their risk of developing type 2 diabetes — and it does so with some adorable helpers.
More than one in three American adults has prediabetes — a serious health condition that often leads to type 2 diabetes and other significant health conditions like blindness, heart attack or stroke. According to newly released CDC data, however, nearly 90 percent of the 84 million people with prediabetes don’t know they have it and aren’t aware of the long-term risks to their health. Currently, about 30 million Americans are living with diabetes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8142351-ad-council-prediabetes/
Every organ donor has the potential to save eight lives, which is the foundation of the new public awareness campaign from the Center for Organ Recovery & Education (CORE). Using multiple channels such as outdoor, television, print and radio advertising, transit wraps, a brand new website and social media, CORE is encouraging individuals to “LiVE: 8” and end the wait by signing up to become an organ and tissue donor.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7253051-center-for-organ-recovery-and-education-launches-live-8/
In new research from U by Kotex®, three in five women surveyed stated it is more difficult to exercise during their period and the majority reported opting for less challenging workouts.
U by Kotex® is hoping to rid barriers with the launch of its latest innovation – U by Kotex® FITNESS. To meet the needs of people experiencing a period, the brand is introducing three new product offerings, including:
• NEW U by Kotex Fitness Tampons with a plastic FITPAK* so you can protect your protection. Durable, compact, and discreet, FITPAK* is designed to keep your tampons ready for use, wherever you stash them.
• NEW U by Kotex Fitness Liners have DualFlex Zones* that move with you to keep protection where you need it.
• NEW U by Kotex Fitness Ultra Thin Pads are shaped to fit and flex with your body, to stay in place so you don’t have to.
To view the multimedia release go to:
https://www.multivu.com/players/English/8073651-u-by-kotex-findyourfitness/
The Council of Community Clinics (CCC), a premier consortium of primary care organizations in Southern California, today announced its new name and branding, Health Center Partners, the new name for its subsidiary formerly known as Community Clinic Health Network, Health Quality Partners, and the launch of Integrated Health Partners. Integrated Health Partners is a fully integrated primary health network designed to advance standards of care, improve outcomes and reduce costs for member community health centers. On the heels of its recently augmented executive leadership team and the addition of new member Community Health Systems, Inc., Health Center Partners today unveiled its innovative vision for meeting the evolving health needs of nearly 800,000 low-income and uninsured Californians at a launch ceremony in San Diego.
To view the multimedia release go to:
http://www.multivu.com/players/English/7774351-health-center-partners-unveils-community-health-vision/
Diabetes initiative and the global fight against the urban diabetes epidemic. These two major metropolitan centres are the first Chinese cites to become part of the global partnership programme, which was initiated in Mexico City in March 2014, followed by Copenhagen in Europe and Houston in the United States last week.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7377451-novo-nordisk-shanghai-diabetes/
Breast cancer now represents one in four of all cancers in women worldwide and touches lives every day. While experiences with the disease may vary, the desire to defeat breast cancer is universal. This year, in honor of a shared vision for a world without this disease, The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign celebrates the power of global solidarity by encouraging people around the world to “Take Action Together to Defeat Breast Cancer.” The 2016 BCA Campaign invites women, men and families to draw inspiration from one another and unite in action on BCAcampaign.com and social media, while supporting lifesaving breast cancer research.
Over the past two decades, The Estée Lauder Companies’ BCA Campaign, launched by the late Evelyn H. Lauder, co-creator of the Pink Ribbon and founder of the Breast Cancer Research Foundation® (BCRF), has been a leading voice for breast cancer awareness around the world, igniting a global movement that has helped save millions of lives and fund innovative breast cancer research. Today, The BCA Campaign is active in more than 70 countries and has raised more than $65 million to support global research, education and medical services, with more than $50 million funding 200 BCRF medical research grants worldwide over the past 22 years. These funds help accelerate critical research across wide-ranging areas such as tumor biology, heredity and ethnicity, lifestyle and prevention, treatment, survivorship and metastasis. Around the world, The BCA Campaign partners with more than 60 breast cancer organizations focused on breast cancer research, education and medical services. This year, The BCA Campaign is committed to raising $6 million in support of its mission to defeat breast cancer through education and medical research.
To view the multimedia release go to:
http://www.multivu.com/players/English/7935851-estee-lauder-bca-campaign-2016/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
